Parenteral Nutrition Global Market Report 2024 - By Share, Growth, Trends, Size, Outlook By 2033

The Business Research Company has updated its global market reports, featuring the latest data for 2024 and projections up to 2033

The Business Research Company offers in-depth market insights through Parenteral Nutrition Global Market Report 2024, providing businesses with a competitive advantage by thoroughly analyzing the market structure, including estimates for numerous segments and sub-segments.

Market Size And Growth Forecast:
The parenteral nutrition market size has grown strongly in recent years. It will grow from $6.48 billion in 2023 to $6.85 billion in 2024 at a compound annual growth rate (CAGR) of 5.8%. The growth in the historic period can be attributed to rising disposable income and urbanization, growing obese population and increasing popularity of noninvasive and minimally invasive aesthetic procedures.

The parenteral nutrition market size is expected to see strong growth in the next few years. It will grow to $8.67 billion in 2028 at a compound annual growth rate (CAGR) of 6.1%. The growth in the forecast period can be attributed to increasing elderly population, rapid urbanization and rise in disposable income, increase in mergers and acquisitions. Major trends in the forecast period include product innovations, use of artificial intelligence in aesthetics, development of focal radio frequency technology, use of laser-assisted liposuction, and partnerships and collaborations.

Get Free Sample Of This Report-
https://www.thebusinessresearchcompany.com/sample.aspx?id=6705&type=smp

Market Segmentation:
The parenteral nutrition market covered in this report is segmented -
1) By Composition: Amino Acids, Fats, Carbohydrates, Trace Elements, Vitamins, Minerals, Other Compositions
2) By Consumer Type: Children and New-born, Adults
3) By End-User: Hospitals, Clinics, Homecare, Other End Users

Major Driver - Rising Prevalence Of Malnutrition Globally Propels Growth In Parenteral Nutrition Market
The growing prevalence of malnutrition across the globe is driving the growth of the parenteral nutrition market. Malnutrition refers to deficiencies, excesses, or imbalances in a person's intake of energy or nutrients. Premature births, which result in immune dysfunction and inadequate nutrition, have increased the demand for and use of parenteral nutrition among children and infants. For example, according to the World Health Organization, a Switzerland-based government agency, in 2021, 1.9 billion adults were overweight or obese, while 462 million were underweight. Around 45% of deaths among children under 5 years of age are linked to undernutrition. Hence, the growing prevalence of malnutrition across the globe is expected to boost demand for parenteral nutrition during the forecast period.

Competitive Landscape:
Major companies operating in the parenteral nutrition market report are Baxter International Inc., Fresenius SE & Co. KGaA, Otsuka Pharmaceutical Factory Inc, B. Braun Melsungen AG, Sichuan Kelun Pharmaceutical Co. Ltd, American Regent Inc, JW Pharmaceutical, Grifols S.A., Amanta Healthcare, ICU Medical Inc., Hubei Provincial Bafeng Pharmaceuticals and Chemicals Share Co. Ltd., Allergan, Vifor Pharma, Pharmasyntez, Horatev, Soleo Health, Enteris BioPharma, Allena Pharmaceuticals, Abbvie, Johnson & Johnson, Sanofi, Biogen Inc., Farmoterápica, Pfizer Inc., Actavis Inc.

Get Access To The Full Market Report -
https://www.thebusinessresearchcompany.com/report/parenteral-nutrition-global-market-report

Top Trend - Innovative Product Introductions Drive Growth In Parenteral Nutrition Market
Product innovation is a major trend in the parental nutrition market. Companies in the parental nutrition market are introducing innovative products, such as four-oil lipid injectable emulsion, to expand the parenteral nutrition portfolio. For instance, in March 2022, Fresenius Kabi, a Germany-based pharmaceutical company, received approval from the United States Food and Drug Administration (US FDA) for SMOFlipid lipid injectable emulsion for pediatric parenteral nutrition, including term and preterm neonates. The SMOFlipid lipid injectable emulsion is the first and only four-oil lipid injectable emulsion that contains soybean oil, medium-chain triglycerides, olive oil, and fish oil, a good source of omega-3 fatty acids. It can be used from the hospital to the home care setting.

The Table Of Content For The Market Report Include:
1. Executive Summary
2. Parenteral Nutrition Market Characteristics
3. Parenteral Nutrition Market Trends And Strategies
4. Parenteral Nutrition Market - Macro Economic Scenario
5. Parenteral Nutrition Market Size And Growth
…..
27. Parenteral Nutrition Market Competitor Landscape And Company Profiles
28. Key Mergers And Acquisitions
29. Future Outlook and Potential Analysis
30. Appendix

Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model"

About The Business Research Company
The Business Research Company (www.thebusinessresearchcompany.com) is a market intelligence firm that pioneers in company, market, and consumer research. Located globally, TBRC's consultants specialize in various industries including manufacturing, healthcare, financial services, chemicals, and technology. The firm has offices located in the UK, the US, and India, along with a network of proficient researchers in 28 countries.

This release was published on openPR.